PharmaNutra among the exhibiting companies of CPhI Japan 2019
After the success of the first participation at the CPhI Worldwide 2018, PharmaNutra presents the innovative Sucrosomial Technology® and Cetilar® line products to the Japanese market at the CPhI Japan 2019.
The CPhI Japan 2019 ended yesterday in Tokyo, the most important pharmaceutical industry fair in the East brought together for three days more than 20,000 professionals and 550 exhibitors from more than 65 countries.
Thanks to the collaboration with ICE, the agency for the internationalization and the foreign promotion of the Italian companies, PharmaNutra participated for the first time at the CPhI Japan as an exhibiting company, with its own stand installed inside the Italian Pavilion.
A unique opportunity to present the two patented product lines: SiderAL® and Cetilar® to the Japanese and beyond to the Asian market. Specifically, the SiderAL® products, based on Sucrosomial Iron®, the innovative absorption mechanism developed by the PharmaNutra Group, have received considerable interest from the pharmaceutical professionals present at the CPhI. In Japan, in fact, iron deficiency is a widespread problem, which particularly affects women during pregnancy.
Andrea Lacorte (President of PharmaNutra S.p.A.) : “The CPhI Japan 2019 represented an important opportunity to establish useful contacts for the development of our business in the Far East, particularly in the Philippines, Taiwan, Hong Kong, South Korea and Japan itself, and we can add Australia for Cetilar®. I found it very interesting what ICE did, bringing together 10 Italian companies, including PharmaNutra, in a dedicated pavilion, offering excellent service to those who decided to tackle such a long trip in an objectively complex market, but at the same time it represents a challenge. And we like the challenges, even the most difficult”.